Mail Us

bd@bioexcelife.com

Call Us

(+91) 974 2291 095
(+91) 703 0321 095

Clinical Evaluation Reports

Comprehensive CER Services for Medical Device Compliance

Bioexcel Medical Device Research Organisation offer

Clinical Evaluation Report (CER): Essential for Regulatory Success

Clinical Evaluation

At Bioexcel, we provide end-to-end support for preparing and updating Clinical Evaluation Reports (CERs) in compliance with EU MDR (2017/745), FDA, and global regulatory requirements. Our expertise ensures your medical device meets safety, performance, and clinical evidence requirements, paving the way for seamless regulatory approvals and market entry.

What is a Clinical Evaluation Report (CER)?

A Clinical Evaluation Report (CER) is a regulatory document required to demonstrate the safety and performance of a medical device using clinical data. Under EU MDR, CERs must be prepared and updated regularly to maintain CE marking and market access.

Key Components of a CER:

  • Clinical evaluation plan and scope.
  • Review of clinical literature and existing clinical data.
  • Analysis of post-market surveillance (PMS) and Post-Market Clinical Follow-Up (PMCF) data.
  • Risk-benefit analysis of the device.
Clinical Evaluation
Why a CER is Crucial
  • Regulatory Compliance: Mandatory for CE marking under EU MDR Annex XIV, FDA submissions, and CDSCO approvals.
  • Demonstrates Safety and Performance: Provides evidence that your device meets its intended purpose with minimal risks.
  • Post-Market Surveillance: Supports ongoing compliance with PMS and PMCF requirements.

Our Clinical Evaluation Report (CER) Services

CER Preparation and Development

Comprehensive CERs Aligned with EU MDR

We prepare complete CERs based on your device’s risk classification, intended use, and clinical evidence requirements.

Key Features:

  • Clinical Evaluation Plan (CEP) preparation as per MEDDEV 2.7/1 Rev. 4.
  • Systematic literature review for existing clinical evidence.
  • Compilation of clinical data from trials, PMS, and PMCF studies.

Gap Analysis and CER Updates

Ensuring Continuous Compliance

We perform gap analyses of existing CERs to identify deficiencies and update them to meet the latest regulatory requirements.

Key Features:

  • Review and alignment of CERs with EU MDR requirements.
  • Inclusion of updated clinical and post-market data.
  • Integration of PMS and PMCF findings.

Literature Review and Data Analysis

Robust Evidence for Regulatory Approval

Our team conducts systematic literature reviews to identify relevant clinical data and evaluate its applicability to your device.

Key Features:

  • Identification of equivalent devices for comparison.
  • Evaluation of clinical safety and performance data.
  • Statistical analysis and interpretation of clinical outcomes.

Risk-Benefit Analysis

Comprehensive Assessment of Safety and Performance

We assess the clinical benefits of your device against potential risks, ensuring alignment with ISO 14971 and EU MDR Annex I.

Key Features:

  • Hazard identification and risk analysis.
  • Clinical evidence-based risk-benefit evaluation.
  • Recommendations for risk control and mitigation.

CER Submission and Regulatory Support

Seamless Submissions for Global Approvals

We provide regulatory-ready CERs and assist with submissions to Notified Bodies, FDA, CDSCO, and other authorities.

Key Features:

  • Preparation of CERs for Class I, IIa, IIb, and III devices.
  • Communication with Notified Bodies to address queries.
  • Support for regulatory audits and reviews.

CER Integration with PMS and PMCF

Ensuring Long-Term Compliance

We align your CER with Post-Market Surveillance (PMS) and Post-Market Clinical Follow-Up (PMCF) activities to maintain ongoing compliance.

Key Features:

  • Development of PMCF plans and protocols.
  • Analysis of real-world evidence and clinical data.
  • Integration of PMS and PMCF findings into CER updates.

Case Studies

Challenge:

A manufacturer needed a CER for a Class III knee implant to maintain CE marking under EU MDR.

Solution by Bioexcel:

  • Conducted a systematic literature review and identified equivalent devices.
  • Compiled clinical data from trials and post-market surveillance.
  • Prepared a detailed CER, including risk-benefit analysis and PMS data integration.

Outcome:

  • Successfully maintained CE marking with zero Notified Body findings.

Challenge:

An IVD manufacturer required an updated CER for their diagnostic kit to comply with MDR requirements.

Solution by Bioexcel:

  • Reviewed existing clinical data and identified gaps in PMS evidence.
  • Integrated real-world evidence from PMCF activities.
  • Updated the CER to align with MDR Annex XIV.

Outcome:

  • Successfully passed Notified Body review, enabling continued market access.

Challenge:

A startup lacked clinical trial data for their wound care device and needed a literature-based CER to support CE marking.

Solution by Bioexcel:

  • Conducted an extensive literature review to identify equivalent devices.
  • Evaluated clinical performance and safety data from published studies.
  • Prepared a CER demonstrating equivalence and compliance with MDR.

Outcome:

  • Achieved CE marking approval within regulatory timelines.

Why Choose Bioexcel for CER Services?

Regulatory Expertise

In-depth knowledge of EU MDR, FDA, and CDSCO requirements.

Tailored Solutions

Customized CERs based on your device’s risk class and intended use.

End-to-End Support

From data collection to Notified Body submissions.

Proven Success

A track record of successful CER approvals for diverse devices.

Help & FAQ

Frequently Asked Questions

All medical devices seeking CE marking under EU MDR, including Class I, IIa, IIb, and III devices, require a CER.

CERs must be updated regularly based on the device’s risk class, typically every 1–3 years, or when significant new data becomes available.

 

Yes, we specialize in literature-based CERs, particularly for devices with limited clinical trial data, by leveraging equivalent device comparisons and published evidence.

Ensure your medical device meets global safety and performance requirements with Bioexcel’s Clinical Evaluation Report (CER) services. Contact us today to streamline your regulatory submissions and maintain compliance.